ABEONA THERAPEUTICS INC.

Abeona Therapeutics Inc.

Biotechnology • Healthcare • Cleveland, OH, United States • ABEO (NCM)

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

646 813 4701 6555 Carnegie Avenue, Cleveland, OH 44103, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
GlobeNewswire • Dec 31
Here's Why Abeona Therapeutics Popped Higher Today - The Motley Fool
The Motley Fool • Nov 12
Abeona Therapeutics Inc. (NASDAQ:ABEO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
MarketBeat • Dec 30
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
Caledonian Record • Dec 31
Should You Invest in Abeona Therapeutics (ABEO)? - Yahoo Finance
Yahoo Finance • Sep 8

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has ABEONA THERAPEUTICS INC. had layoffs?
No layoff events have been recorded for ABEONA THERAPEUTICS INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does ABEONA THERAPEUTICS INC. have?
ABEONA THERAPEUTICS INC. has approximately 136 employees.
What industry is ABEONA THERAPEUTICS INC. in?
ABEONA THERAPEUTICS INC. operates in the Biotechnology industry, within the Healthcare sector.
Is ABEONA THERAPEUTICS INC. a publicly traded company?
Yes, ABEONA THERAPEUTICS INC. is publicly traded under the ticker symbol ABEO on the NCM. The company has a market capitalization of approximately $0.29 billion.
Where is ABEONA THERAPEUTICS INC. headquartered?
ABEONA THERAPEUTICS INC. is headquartered in Cleveland, OH, United States at 6555 Carnegie Avenue, Cleveland, OH 44103, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.